Zenotech Laboratories Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 683231,
    "name": "Zenotech Lab.",
    "stock_name": "Zenotech Lab.",
    "full_name": "Zenotech Laboratories Ltd",
    "name_url": "stocks-analysis/zenotech-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "44.78",
    "chg": 0.78,
    "chgp": "1.77%",
    "dir": 1,
    "prev_price": "44.00",
    "mcapval": "269.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532039,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE486F01012",
    "curr_date": "Jun 24, 03:30 PM",
    "curr_time": "02:36 AM",
    "last_traded_at": "Jun 24, 03:30 PM IST",
    "bse_nse_vol": "5.14 k",
    "exc_status": "Active",
    "traded_date": "Jun 24, 2026",
    "traded_date_str": "2026 06 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/zenotech-lab-683231-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Zenotech Laboratories Downgraded to Strong Sell Amid Deteriorating Fundamentals and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zenotech-laboratories-downgraded-to-strong-sell-amid-deteriorating-fundamentals-and-bearish-technicals-4069815",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ZenotechLaborat_mojoScore_4069815.png",
        "date": "2026-06-24 08:20:03",
        "description": "Zenotech Laboratories Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 23 June 2026, reflecting deteriorating fundamentals and increasingly negative technical indicators. The pharmaceutical micro-cap’s recent financial results, valuation metrics, and technical trends collectively triggered this reassessment, signalling heightened caution for investors."
      },
      {
        "title": "Zenotech Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zenotech-laboratories-ltd-upgraded-to-sell-on-technical-improvements-despite-financial-challenges-4062759",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ZenotechLaborat_mojoScore_4062759.png",
        "date": "2026-06-19 08:12:37",
        "description": "Zenotech Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 18 Jun 2026, reflecting a nuanced shift in technical indicators despite ongoing financial challenges. The micro-cap pharmaceutical company’s Mojo Score has improved to 34.0, signalling a cautious but more optimistic stance from analysts amid mixed signals across quality, valuation, financial trends, and technicals."
      },
      {
        "title": "Zenotech Laboratories Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zenotech-laboratories-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-4053663",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ZenotechLaborat_mojoScore_4053663.png",
        "date": "2026-06-15 08:10:59",
        "description": "Zenotech Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating as of 13 June 2026. This revision reflects deteriorating financial performance, expensive valuation metrics, and a shift towards bearish technical indicators, signalling heightened risks for investors."
      },
      {
        "title": "Zenotech Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zenotech-laboratories-ltd-upgraded-to-sell-on-technical-improvements-despite-financial-challenges-4040516",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ZenotechLaborat_mojoScore_4040516.png",
        "date": "2026-06-09 08:50:27",
        "description": "Zenotech Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 8 June 2026, driven primarily by a shift in technical indicators despite ongoing financial headwinds. The micro-cap pharmaceutical company’s Mojo Score improved to 34.0, reflecting a nuanced balance between technical recovery and persistent valuation and profitability concerns."
      },
      {
        "title": "Zenotech Laboratories Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zenotech-laboratories-ltd-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-4030255",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ZenotechLaborat_mojoScore_4030255.png",
        "date": "2026-06-02 09:03:14",
        "description": "Zenotech Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating as of 1 June 2026. This revision reflects deteriorating financial performance, expensive valuation metrics, and increasingly bearish technical indicators, signalling heightened risks for investors amid ongoing underperformance relative to benchmark indices."
      },
      {
        "title": "Zenotech Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zenotech-laboratories-ltd-upgraded-to-sell-on-technical-improvements-despite-financial-challenges-4012973",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZenotechLaborat_mojoScore_4012973.png",
        "date": "2026-05-26 08:45:59",
        "description": "Zenotech Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift in technical indicators despite ongoing financial challenges. The company’s micro-cap status, combined with a complex interplay of valuation, quality, financial trends, and technical signals, has led to this recalibration of its market outlook as of 25 May 2026."
      },
      {
        "title": "Zenotech Laboratories Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zenotech-laboratories-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-3998334",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZenotechLaborat_mojoScore_3998334.png",
        "date": "2026-05-19 08:39:20",
        "description": "Zenotech Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The downgrade reflects deteriorating fundamentals, weak quarterly results, and increasingly bearish technical signals, signalling caution for investors in this micro-cap pharmaceutical stock."
      },
      {
        "title": "Zenotech Laboratories Ltd Rating Upgraded to Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zenotech-laboratories-ltd-rating-upgraded-to-sell-amid-mixed-financial-and-technical-signals-3986879",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZenotechLaborat_mojoScore_3986879.png",
        "date": "2026-05-12 08:42:03",
        "description": "Zenotech Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators despite ongoing financial challenges. This nuanced change reflects a mildly improved technical outlook amid persistent valuation and profitability concerns, offering investors a complex picture of the micro-cap pharmaceutical player’s current standing."
      },
      {
        "title": "Zenotech Laboratories Downgraded to Strong Sell Amidst Deteriorating Financial and Technical Indicators",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zenotech-laboratories-downgraded-to-strong-sell-amidst-deteriorating-financial-and-technical-indicators-3975257",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZenotechLaborat_mojoScore_3975257.png",
        "date": "2026-05-05 08:41:45",
        "description": "Zenotech Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating following a marked deterioration in its financial performance, valuation metrics, and technical indicators. The pharmaceutical company’s quarterly results for March 2026 reveal significant declines in profitability and sales, while technical trends have shifted to bearish, signalling increased caution for investors."
      }
    ],
    "total": 143,
    "sid": "683231",
    "stock_news_url": "https://www.marketsmojo.com/news/zenotech-laboratories-683231"
  },
  "announcements": [
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "27-May-2026",
      "details": "Submission of Annual Secretarial Compliance Report for the financial year 2025-26",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "30-Apr-2026",
      "details": "Copies of extract of Audited Standalone Financial Results of the Company for the quarter and financial year ended March 31 2026 as published in todays newspaper i.e. April 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On April 29 2026",
      "datetime": "29-Apr-2026",
      "details": "Submission of Audited Standalone Financial Results for the quarter and financial year ended March 31 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Zenotech Laboratories Ltd has announced <strong>17:22</strong> rights issue, ex-date: 01 Jun 17",
          "dt": "2017-06-01",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Zenotech Laboratories Downgraded to Strong Sell Amid Deteriorating Fundamentals and Bearish Technicals

2026-06-24 08:20:03

Zenotech Laboratories Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 23 June 2026, reflecting deteriorating fundamentals and increasingly negative technical indicators. The pharmaceutical micro-cap’s recent financial results, valuation metrics, and technical trends collectively triggered this reassessment, signalling heightened caution for investors.

Read full news article

Zenotech Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges

2026-06-19 08:12:37

Zenotech Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 18 Jun 2026, reflecting a nuanced shift in technical indicators despite ongoing financial challenges. The micro-cap pharmaceutical company’s Mojo Score has improved to 34.0, signalling a cautious but more optimistic stance from analysts amid mixed signals across quality, valuation, financial trends, and technicals.

Read full news article

Zenotech Laboratories Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals

2026-06-15 08:10:59

Zenotech Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating as of 13 June 2026. This revision reflects deteriorating financial performance, expensive valuation metrics, and a shift towards bearish technical indicators, signalling heightened risks for investors.

Read full news article

Zenotech Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges

2026-06-09 08:50:27

Zenotech Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 8 June 2026, driven primarily by a shift in technical indicators despite ongoing financial headwinds. The micro-cap pharmaceutical company’s Mojo Score improved to 34.0, reflecting a nuanced balance between technical recovery and persistent valuation and profitability concerns.

Read full news article

Zenotech Laboratories Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals

2026-06-02 09:03:14

Zenotech Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating as of 1 June 2026. This revision reflects deteriorating financial performance, expensive valuation metrics, and increasingly bearish technical indicators, signalling heightened risks for investors amid ongoing underperformance relative to benchmark indices.

Read full news article

Zenotech Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges

2026-05-26 08:45:59

Zenotech Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift in technical indicators despite ongoing financial challenges. The company’s micro-cap status, combined with a complex interplay of valuation, quality, financial trends, and technical signals, has led to this recalibration of its market outlook as of 25 May 2026.

Read full news article

Zenotech Laboratories Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals

2026-05-19 08:39:20

Zenotech Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The downgrade reflects deteriorating fundamentals, weak quarterly results, and increasingly bearish technical signals, signalling caution for investors in this micro-cap pharmaceutical stock.

Read full news article

Zenotech Laboratories Ltd Rating Upgraded to Sell Amid Mixed Financial and Technical Signals

2026-05-12 08:42:03

Zenotech Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators despite ongoing financial challenges. This nuanced change reflects a mildly improved technical outlook amid persistent valuation and profitability concerns, offering investors a complex picture of the micro-cap pharmaceutical player’s current standing.

Read full news article

Zenotech Laboratories Downgraded to Strong Sell Amidst Deteriorating Financial and Technical Indicators

2026-05-05 08:41:45

Zenotech Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating following a marked deterioration in its financial performance, valuation metrics, and technical indicators. The pharmaceutical company’s quarterly results for March 2026 reveal significant declines in profitability and sales, while technical trends have shifted to bearish, signalling increased caution for investors.

Read full news article

View All News